Scientific Research News

Stay updated on research with press releases highlighting industry news, trends, and innovations driving scientific studies and academic research. Explore opportunities in research methodologies, peer-reviewed publications, and collaborative projects.

Jul 28, 2025 at 6:42 PM

Harmonic Announces IMO Gold Medal-Level Performance & Launch of First Mathematical Superintelligence (MSI) AI App

PALO ALTO, Calif.--(BUSINESS WIRE)--Harmonic, the AI lab that introduced the concept of Mathematical Superintelligence (MSI), today launches Aristotle – the only AI model built from the ground up to be hallucination-free. In a livestream on X, the company released its waitlist (aristotle.harmonic.fun) for the Aristotle iOS app beta, with rollout commencing today. Harmonic also announced that Aristotle is among the first AI models to achieve formally verified gold medal-level performance on the...
Jul 28, 2025 at 6:03 PM

Flashpoint Therapeutics Appoints Barry Labinger as Chief Executive Officer

EVANSTON, Ill.--(BUSINESS WIRE)--Flashpoint Therapeutics, a clinical-stage biotechnology company developing a new class of precision-engineered structural nanomedicines, today announced the appointment of Barry Labinger as Chief Executive Officer. With more than three decades of executive experience in the biopharmaceutical industry, Barry brings a proven track record of building and leading innovative life sciences organizations through critical phases of growth, development, and commercializa...
Jul 28, 2025 at 5:09 PM

FDA Informs Sarepta That It Recommends That Sarepta Remove Its Pause and Resume Shipments of ELEVIDYS for Ambulatory Individuals With Duchenne Muscular Dystrophy

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that the U.S. Food and Drug Administration (FDA) notified Sarepta that it may lift its voluntary pause on shipments of ELEVIDYS (delandistrogene moxeparvovec) for ambulatory patients with Duchenne. Sarepta will resume shipping ELEVIDYS to sites of care for treatment of ambulatory patients with Duchenne imminently. “Last week, at the suggestion...
Jul 28, 2025 at 4:16 PM

Bristol Myers Squibb and Bain Capital Create New Company Dedicated to Developing Innovative Immunology Therapies that Address the Unmet Medical Needs of Patients

PRINCETON, N.J. & BOSTON--(BUSINESS WIRE)--Bristol Myers Squibb and Bain Capital Create New Company Dedicated to Developing Innovative Immunology Therapies that Address the Unmet Medical......
Jul 28, 2025 at 4:15 PM

Bio-Rad Appoints Rajat Mehta Executive Vice President, Global Commercial Operations

HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the appointment of Rajat Mehta as its new Executive Vice President, Global Commercial Operations, effective August 4, 2025. Mehta will lead Bio-Rad's global commercial strategy and execution, succeeding Mike Crowley, who is retiring after a distinguished 26-year career with the company. Mehta brings extensive leadership...
Jul 28, 2025 at 12:15 PM

Exosome Research Global Market Forecasts 2025-2030 | Kits & Reagents Segment to Lead Growth Due to Increased Demand for Standardized Tools - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Exosome Research Market by Offering (Kits, Reagents (Antibodies, Isolation, Purification), Instruments, Services), Indication (Cancer, Infectious Diseases), Application (Biomarkers, Vaccines), Manufacturing Services (Stem Cell) - Global Forecast to 2030" report has been added to ResearchAndMarkets.com's offering. The global exosome research market is projected to reach USD 480.6 million by 2030 from USD 214.4 million in 2025, at a CAGR of 17.5% during the forecast...
Jul 28, 2025 at 11:44 AM

Paragonix to Spotlight Breakthrough Research in Solid Organ Transplantation at the 2025 World Transplant Congress

WALTHAM, Mass.--(BUSINESS WIRE)--Paragonix Technologies, Inc., a pioneer in advanced organ transplant preservation and surgical services, is proud to announce an impactful presence at the upcoming World Transplant Congress (WTC) 2025, taking place August 2–6 at the Moscone Center in San Francisco, California. A series of oral and poster presentations at the conference will showcase new clinical findings from the GUARDIAN Registries, in addition to independent clinical analyses, emphasizing the...
Jul 28, 2025 at 9:18 AM

Thermo Fisher Scientific Showcases Diagnostics Solutions Designed to Meet Evolving Global Healthcare Demands at ADLM 2025

CHICAGO--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, showcases its innovations in improving clinical and diagnostic laboratory efficiency and workflow optimization during the Association for Diagnostics & Laboratory Medicine Conference (ADLM), July 27-31, 2025, in Chicago, Ill. The company debuts two new solutions, LabLink360™* and Thermo Scientific™ MAS™ Max quality controls, designed to support quality control assurance and streamline workflows in clini...
Jul 28, 2025 at 9:00 AM

Improving Next-Generation Aircraft With Argonne’s Aurora Supercomputer and AI

LEMONT, Ill.--(BUSINESS WIRE)--Researchers use Aurora to boost aircraft efficiency and performance....
Jul 28, 2025 at 8:30 AM

AngioDynamics Enrolls First Patient in AMBITION BTK Trial Advancing Treatment for Critical Limb Ischemia

LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving patient quality of life, today announced enrollment of the first patient in the Randomized Study of the Auryon Atherectomy System Used in Combination with Standard Balloon Angioplasty Versus Standard Balloon Angioplasty Alone Treating Infrapopliteal Lesions in Subjects with Critical...
Turn Your News Into Headlines
Submit Your Release

Get Story Ideas Delivered to Your Inbox

Sign Up